Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof

Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof

US Patent 9149427 · Granted Oct 6, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of encapsulated cell therapy for treatment of ophthalmic disorders2025
Use of encapsulated cell therapy for treatment of ophthalmic disorders2025
Use of encapsulated cell therapy for treatment of ophthalmic disorders2025
Use of encapsulated cell therapy for treatment of ophthalmic disorders2021
Use of encapsulated cell therapy for treatment of ophthalmic disorders2021
Use of encapsulated cell therapy for treatment of ophthalmic disorders2019
Use of encapsulated cell therapy for treatment of ophthalmic disorders2019
Use of encapsulated cell therapy for treatment of ophthalmic disorders2019
Use of encapsulated cell therapy for treatment of ophthalmic disorders2019
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors2018
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors2018
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors2018